Mantell M P, Ziegler T R, Adamson W T, Roth J A, Zhang W, Frankel W, Bain A, Chow J C, Smith R J, Rombeau J L
Department of Surgery, University of Pennsylvania Hospital, Philadelphia 19104, USA.
Am J Physiol. 1995 Dec;269(6 Pt 1):G974-80. doi: 10.1152/ajpgi.1995.269.6.G974.
The effects of exogenous insulin-like growth factor-I (IGF-I) on colonic adaptation were examined in male Sprague-Dawley rats (n = 60, 225-275 mg) after either a 60% small bowel and cecal resection (RX) or mid-small bowel transection with reanastomosis (TX). Animals received a 7-day treatment with either IGF-I (2.4 mg.kg-1.day-1) or vehicle (V; 0.1 mol/l acetic acid). Body weight decreased significantly after resection (-25.6 +/- 4.0 g; P < 0.05 vs. TX/V). IGF-I treatment significantly reduced weight loss after resection (-12.4 +/- 3.8 g; P < 0.01 vs. RX/V) and induced significant weight gain after transection (15.6 +/- 4.0 g; P < 0.05 vs. TX/V). Plasma IGF-I decreased with resection (526 +/- 41 TX/V vs. 344 +/- 17 ng/ml RX/V; P < 0.01). IGF-I treatment significantly increased plasma IGF-I levels (805 +/- 100 ng/ml TX/IGF, 677 +/- 56 ng/ml RX/IGF). After resection, IGF-I treatment significantly increased colonic mucosal weight, DNA, protein content, and crypt depth when compared with resection alone (P < 0.05). Colonic water absorption, measured by an in vivo [3H]polyethylene glycol assay, was significantly increased by IGF-I treatment in resected animals (399 +/- 23 RX/IGF vs. 306 +/- 32 microliter.cm-1.h-1 RX/V; P < 0.05). Resection resulted in increased steady-state colonic IGF-I mRNA (182% of TX/V; P < 0.01) without significantly affecting IGF-I receptor mRNA expression. Regulation of IGF binding protein (BP)-3 and -4 was discoordinate, with IGFBP-3 mRNA tending to decrease with resection (67% of TX/V; P is not significant) and IGFBP-4 increasing significantly (191% of TX/V; P < 0.05). An important role for IGF-I in colonic adaptation after massive intestinal resection is indicated by 1) significantly enhanced colonic mucosal growth and water absorption with IGF-I treatment and 2) postresection upregulation of colonic IGF-I mRNA and alteration of IGFBP-3 and IGFBP-4 mRNA expression.
在雄性Sprague-Dawley大鼠(n = 60,体重225 - 275毫克)中,分别进行60%小肠和盲肠切除(RX)或小肠中段横断并吻合(TX)后,研究外源性胰岛素样生长因子-I(IGF-I)对结肠适应性的影响。动物接受为期7天的IGF-I(2.4毫克·千克⁻¹·天⁻¹)或赋形剂(V;0.1摩尔/升乙酸)治疗。切除术后体重显著下降(-25.6 ± 4.0克;与TX/V相比,P < 0.05)。IGF-I治疗显著减轻了切除术后的体重减轻(-12.4 ± 3.8克;与RX/V相比,P < 0.01),并在横断术后诱导显著体重增加(15.6 ± 4.0克;与TX/V相比,P < 0.05)。血浆IGF-I随着切除而降低(TX/V为526 ± 41,RX/V为344 ± 17纳克/毫升;P < 0.01)。IGF-I治疗显著提高了血浆IGF-I水平(TX/IGF为805 ± 100纳克/毫升,RX/IGF为677 ± 56纳克/毫升)。切除术后,与单纯切除相比,IGF-I治疗显著增加了结肠黏膜重量、DNA、蛋白质含量和隐窝深度(P < 0.05)。通过体内[³H]聚乙二醇测定法测量,IGF-I治疗显著增加了切除动物的结肠水吸收(RX/IGF为399 ± 23,RX/V为306 ± 32微升·厘米⁻¹·小时⁻¹;P < 0.05)。切除导致结肠IGF-I mRNA稳态增加(为TX/V的182%;P < 0.01),而对IGF-I受体mRNA表达无显著影响。IGF结合蛋白(BP)-3和-4的调节不协调,IGFBP-3 mRNA倾向于随着切除而降低(为TX/V的67%;P无统计学意义),而IGFBP-4显著增加(为TX/V的191%;P < 0.05)。IGF-I在大规模肠道切除术后结肠适应性中的重要作用体现在:1)IGF-I治疗显著增强了结肠黏膜生长和水吸收;2)切除术后结肠IGF-I mRNA上调以及IGFBP-3和IGFBP-4 mRNA表达改变。